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Abstract.  B lymphocytes from patients with I-cell dis- 
ease (ICD) maintain normal cellular levels of 
lysosomal enzymes despite a deficiency of the enzyme 
UDP-N-acetylglucosamine: lysosomal enzyme 
N-acetylglucosamine-l-phosphotransferase.  We find 
that an ICD B lymphoblastoid cell line targets about 
45 % of the lysosomal protease cathepsin D  to dense 
lysosomes. This targeting occurs in the absence of de- 
tectable mannose 6-phosphate residues on the cathep- 
sin D  and is not observed in ICD fibroblasts. The 
secretory protein pepsinogen,  which is closely related 
to cathepsin D  in both amino acid sequence and three- 
dimensional  structure,  is mostly excluded from dense 
lysosomes, indicating that the lymphoblast targeting 
pathway is specific. Carbohydrate residues are not 
required for lysosomal targeting,  since a non- 
glycosylated mutant cathepsin D  is sorted with com- 
parable efficiency to the wild type protein.  Analysis of 
a number of cathepsin D/pepsinogen chimeric proteins 
indicates that an extensive polypeptide determinant in 
the cathepsin D  carboxyl lobe can confer efficient 
lysosomal sorting when introduced into the pepsinogen 
sequence. This determinant overlaps but is not identi- 
cal to the recognition marker for phosphotransferase. 
These results indicate that a  specific protein recogni- 
tion event underlies Man-6-P-independent  lysosomal 
sorting in ICD lymphoblasts. 
M 
OST lysosomal enzymes are soluble glycoproteins 
which, along with secretory proteins,  are cotrans- 
lationaUy inserted into the lumen of the rough ER 
and glycosylated at selected asparagine  residues by the en 
bloc transfer of a large preformed oligosaccharide (reviewed 
in  Kornfeld  and  MeUman,  1989).  In  normal  mammalian 
cells,  the N-linked  oligosaccharides  of the lysosomal en- 
zymes are subsequently modified by the concerted action of 
the  enzymes  UDP-GIcNAc:  lysosomal enzyme N-acetyl- 
glucosamine-l-phosphotransferase  (phosphotransferase)  and 
N-acetylglucosamine-l-phosphate  tx-N-acetylgluco samini- 
dase to generate an exposed mannose 6-phosphate (Man-6-P)~ 
moiety. Lysosomal enzymes bearing phosphomannosyl resi- 
dues bind to Man-6-P receptors present in the TGN and are 
then transported to an acidified prelysosomal compartment 
by means  of clathrin-coated  vesicles.  Pbospbotransferase 
selects these acid hydrolases for modification by recognizing 
a  conformation-dependent  protein determinant present on 
lysosomal enzymes but not on structurally related secretory 
proteins (Baranski,  1990, 1991). 
I-cell disease (ICD)  is  an  inherited  human  disorder in 
which an unknown mutation eliminates  or severely reduces 
the activity of phosphotransferase  (Reitman  et al.,  1981; 
1. Abbreviations used in this paper: BLCL, B lymphoblastoid  cell line; 
EBV, Epstein-Barr virus; endo H, endoglycosidase  H; ICD, I-cell  disease; 
Man-6-P, mannose 6-phosphate. 
Hasilik et al.,  1981). As a result,  newly synthesized  lyso- 
somal enzymes do not acquire Man-6-P residues and are 
quantitatively  secreted by many cell types. This results  in 
gross cellular deficiencies  of most lysosomal enzymes and 
severe clinical  manifestations  in the first few years of life 
(Nolan and Sly, 1989).  However,  certain tissues and cell 
types isolated from ICD patients,  such as liver and spleen 
(Waheed et al., 1982; Owada and Neufeld, 1982) and B lym- 
phocytes immortalized by Epstein-Barr virus (EBV) (Little 
et al., 1987; Okada et al., 1988; Tsuji et al., 1988), have cel- 
lular lysosomal enzyme levels within the normal range  for 
those cell types despite virtually undetectable phosphotrans- 
ferase activity. In B lymphocytes, these enzymes have been 
localized  to a dense membrane compartment likely repre- 
senting lysosomes (Miller, A. L., M. Liddle, V. Norton, and 
D. Wright.  1988. J.  Cell Biol.  107:341a), and a recent report 
indicates  that newly synthesized lysosomal enzymes are re- 
tained  intracellularly  in  the  absence  of phosphorylation 
(DiCioccio and Miller,  1991). 
The ability of these cells to retain intracellular  lysosomal 
enzymes in the absence of phosphotransferase  activity sug- 
gests  that  they may have  a  cell type-restricted,  Man-6-P 
-independent mechanism  of lysosomal enzyme targeting. 
We decided to investigate this possibility further by studying 
an established B lymphoblastoid cell line derived from an 
ICD patient (described in Little et al.,  1987). We find that 
in these cells, both endogenous and transfected cathepsin D, 
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without acquiring Man-6-P residues, consistent with previ- 
ous reports on other lysosomal hydrolases. Furthermore, we 
find that transfected pepsinogen,  the related nonlysosomal 
protease, is largely excluded from lysosomes, indicating that 
ICD lymphoblasts target lysosomal enzymes selectively.  Fi- 
nally,  we present evidence  that an extended protein deter- 
minant in the carboxyl lobe of cathepsin D directs its lyso- 
somal sorting in these cells. 
Materials and Methods 
Materials 
Rabbit  antisera  to human  cathepsin  D  have been described  previously 
(Baranski et al., 1990; Grifliths et al., 1988). Immobilized bovine Man-6- 
P/IGF-II receptor (MPR) was prepared as described previously (Varki and 
Kornfeld, 1983). Rabbit antisera to human pepsinogen were generated by 
injection of the purified protein (gift of Dr. L Michael Samioff, University 
of California, LOs Angeles, CA). EXPRE35S35S protein-labeling mix was 
from DuPont/NEN  (Wilmington,  DE).  All  restriction  and  other DNA 
modifying enzymes were from New England Biolabs (Beverley, MA) or 
Promega Biotec (Madison, WI).  Endoglycosidase H (Endo H) was from 
Boehringer Mannheim Biochemicals (Mountain View, CA).  Vibrio chol- 
erae neuraminidase  and  hygromycin B  were  from Calbiochem-Behring 
Corp. (San Diego, CA). Percoll was from Pharmacia Fine Chemicals (Pis- 
caraway, NJ). All other chemicals were from Sigma Immtmochemicals (St. 
Louis, MO). 
Cell Culture and Transfection 
A B lymphoblastoid cell line (BLCL) derived  from an ICD patient was 
kindly provided by Dr. A. L. Miller (University of California, San Diego, 
CA) and has been described (Little et al., 1987). CGM-1, a BLCL derived 
from a normal individual, was provided by Dr. S. Korsmeyer (Washington 
University, St. Louis, MO). The cells were maintained in RPMI 1640, 10% 
bovine calf serum (Hyclone, Logan, UT),  100 U/ml penicillin,  100 U/ml 
streptomycin at a density of 3-5  ×  105/ml in a humidified 5%  CO2 at- 
mosphere. Skin fibroblasts from normal individuals and ICD patients, ob- 
tained from the Human Genetics Mutant Cell Repository (Bethesda, MD), 
were maintained in MEM-c~, 10% FCS (Hazleton Biologics, Lexena, KS), 
100 U/mi penicillin,  100 U/ml streptomycin. 
ICD lymphoblasts were electroporated essentially as in Margolskee et al. 
(1988). All procedures were carried out under aseptic conditions. 5  ×  107 
cells in logarithmic growth phase were pelleted, washed once with PBS, and 
resuspended in 500/~1 HEPES buffered saline containing 100-150/~g plas- 
mid DNA and 300/~g sheared salmon sperm DNA. Mock transfections re- 
ceived 500 ttg salmon sperm DNA only. Ceils were transferred to sterile, 
washed plastic cuvettes (Fisher Scientific Co., Pittsburgh, PA), electropo- 
rated at room temperature with a BTX electroporator using a capacitor dis- 
charge of 150 V, 1,050 ttF (pulse length 6-9 ms). Electroporated cells were 
maintained at 5 ×  105/ml for 48 h in the absence of selection, and then in 
media containing 100 U/mi hygromycin B for 2 d, 150 U/ml for 3 d, and 
200 U/nil thereafter. During selection, cells were maintained at a density 
of 5 ×  105/ml in a 50%/50% mixture of fresh and ICD BLCL-conditionnd 
media and were fed every 2 to 3 d. Transfected cell lines were maintained 
in completeRPMI 1640 medium containing 200 U/ml hygromycin B. 
Plasmid Constructions 
All recombinant DNA techniques used standard protocols (Maniatis et al., 
1989). The cDNA for human cathepsin D (Faust et ai., 1985), subcloned 
into pSP64,  was excised by digestion with HindllI and NaeI. The genera- 
tion of the nonglycosylated mutant cathepsin D eDNA has been described 
previously  (Cantor  and Kornfeld,  1992) and was excised similarly. The 
eDNA for human glycopepsinogen, subcloned into pSP64 (Baranski et al., 
1990), was digested with EeoRI, blunt ended with Klenow fragment, and 
excised with HindHI. Insert fragments were gel purified and ligated into the 
plasmid EBO pLPP (a modified version of  plasmid EBO peD; Margolskee 
et al., 1988; gift of P. Kavathas, Yale University, New Haven, CT), which 
had been cut with XbaI (blunted) and HindlII.  Ligation mixes were used 
to transform Escherichia coli DH5o~, plasmids were isolated and the con- 
structs confirmed by restriction  mapping. The chimeric constructs  CP2, 
CP3, CP4, CP5, CP6, CP17, CP51, CP52, CP55, CP56, CP65, and CP69 
have been described previously (Baranski et al.,  1990, 1991, 1992). The 
constructs CP71, CP72,  and CP73 were assembled from restriction frag- 
ments of previously published constructs using shared Hinfl, PvulI,  and 
BamHI restriction sites. Plasmid constructs were confirmed by restriction 
mapping and DNA sequencing where appropriate.  The chimeric cDNAs 
were  subcloned  into  EBO  pLPP  after  subcloning  in  Bluescript  SK 
(Stratagene Corp., La Jolla, CA) or pGEM3Zf(-) (Promega Biotec) to ac- 
quire flanking restriction sites. 
Metabolic Labeling and Immunoprecipitation 
1-1.5  ×  106  cells  in  logarithmic  growth  phase  were  washed  twice  in 
methionine-free, glutamine-free RPMI  1640, 10% dialyzed FCS, 25 mM 
Hepes-NaOH,  pH 7.4, 100 U/mi penicillin,  100 U/ml streptomycin, and 
resuspended in this media at ~5  x  106 cells/ml.  EXPRE35S35S labeling 
mix was added to 0.25 mCi/mi (methionine), and cells were incubated as 
described in the Results section. Chase was initiated by the addition of cold 
methionine to 5 mM and continued as described  in Results. In some experi- 
ments, cells were incubated for 1 h before labeling in methionine-free media 
containing 200/~M  leupeptin,  200/~M  pepstatin A. 
At the end of  the chase, cells were harvested by centrifugation for 1 min- 
ute in a microfuge at 4°C. The media was decanted and saved, and the cells 
were washed twice with 1 ml ice-cold PBS plus 2 mM methionine and lysed 
in 200/zl PBS, 10 mM EDTA, 0.5% Triton X-100, pH 7.4 supplemented 
with 1 mM PMSE 0.25 TIU/ml aprotinin, and Ix of a protease inhibitor 
cocktail containing 2/~g/ml  (final) antipain,  chymostatin,  leupeptin,  and 
pepstatin A. The lysate was sonicated on ice with 3 10-s bursts at 80 W 
using a probe  sonicator  (Branson Ultrasonics Corp., Danbury, CT),  in- 
cubated on ice for 15-30 minutes, and spun for 30 rain at 40000 g, 4°C 
in a Sorvall SS34 rotor. The supernatant was decanted and used for immu- 
noprecipitation. 
Cell and media samples were adjusted to 0.1 M Tris-HCl, 0.1 M KCI, 
5  mM  MgC12, 1%  TX100, 0.5%  Na deoxycholate, 0.3% SDS, 1 mM 
PMSF, pH 8.0, and rabbit antisera to cathepsin D or pepsinogen were added 
as appropriate (CP52, 55, 56, and 69 were immunoprecipitated with anti- 
cathepsin  D;  all other chimeric  proteins  were immunoprecipitated  with 
anti-pepsinogen). Samples were incubated for 6-16 h at 4°C with constant 
mixing. 25/~1 of protein A-agarose (Repligen) was added, and the incuba- 
tion was continued for another 60 min at 4°C. Agarose beads were pelleted 
by 10-s centrifugation in a microfuge, washed four times with 500 t~l 0.1 M 
Tris-HCl,  0.1 M NaC1, 1% TX-100, pH 8.0, and then twice with 500/zl 
0.1 M  Tris-HC1, pH 8.0. Immunoprecipitates  were eluted by heating to 
100°C for 5 min in nonreducing SDS sample buffer and loaded on 10% 
SDS-polyacrylamide  gels (Laemmli,  1970). Gels were fixed and stained 
with Coomassie blue,  impregnated with Amplify fluorographic enhancer 
(Amersham  Corp., Arlington  Heights,  IL),  dried,  and then exposed to 
preflashed Kodak XAR film (Eastman Kodak, Rochester, NY). 
Radioactive bands were quantitated by densitometric scanning or by ex- 
cising the appropriate region of  the dried gel and solubilizing in 30% H202 
at 50°C. 10 ml ScintiVerse  I (Fisher Scientific Co.) was added, and samples 
were counted in a liquid scintillation counter (LS 6800; Beckman Instru- 
ments). 
PercoU Gradient Fractionation 
All operations were carried out at 4°C. [35S]methionine-labeled  cells were 
collected by l-min centrifugation in a microfuge, washed twice with ice-cold 
PBS, and once with ice-cold homogenization buffer (0.25 M sucrose,  10 
mM triethanolamine-HC1, 1 mM EDTA, pH 7.4), and resuspended in 500 
#1 homogenization buffer plus protease inhibitors (see above). Ceils were 
homogenized by 15 passes through a 200/~1 pipet tip fitted to a 1-cc syringe 
and centrifuged for 10 min at 500 g. The supernatant was decanted,  and 
the pellet was resuspended  in 300 ~,l homogenization buffer, rehomoge- 
nized, and spun as above. The pooled postnuclear supernatants were applied 
to 11 ml 36% Percoll (in homogenization buffer) layered on a 2 ml cushion 
of 1.25 M sucrose in a 16 ×  102 mm Ultra Clear centrifuge tube (Beckman 
Instruments,  Inc., Palo Alto,  CA). The gradient  was centrifuged for 90 
minutes at 35,000 g in a rotor (SS34; SorvaU Instruments,  Newton, CT), 
and 1 ml fractions were collected through a needle hole in the bottom of 
the tube. After removal of Percoll by high-speed centrifugation,  fractions 
were immunoprecipitated with antisera to cathepsin D or pepsinogen, and 
assayed  for marker  enzymes  as  described  elsewhere  in  Materials  and 
Methods. Density of fractions was determined by direct weighing and by 
refractometry. 
The Journal of Cell Biology, Volume 123, 1993  100 Oligosaccharide Analysis 
Endo H digestion and Man-6-P  receptor affinity  chromatography  were per- 
formed as described previously  (Baranski et al., 1990). For neuraminidase 
digests, samples were adjusted to 50 mM MES-NaOH, 5 mM CaC12, 0.1% 
TX-100, 1 mM PMSF, pH 6.0, and 6 mU ~qbrio cholerae neuraminidase 
were added. After 4-6 h at 37°C, digestion was terminated by placing the 
sample on ice and adding  immunoprecipitation  buffer. Immunoprecipitation 
was performed as described above. 
Pepstatin Binding Assays 
50 #l [35S]metliionine-labeled  cell lysate or media samples were added to 
500 #1 of a 1:10 slurry of pepstatin A-agarose  (Sigma Immunochemicals) 
equilibrated in 50 mM Na acetate/150 mM NaC1/0.5% TX-100, 0.5 mM 
PMSE 0.25 TIU/ml aprotinin, 10 #M leupeptin, pH 3.6, rapidly mixed, and 
then incubated overnight  at 4°C with constant mixing. After removal  of the 
unbound fraction, the agarose  beads were washed five  times with this buffer 
and then incubated  with 250 #150 mM Tris-HC1, 150 mM NaC1, 0.5 % TX- 
100, pH 8.0. The unbound  and pH 8.0 eluted fractions  were immunoprecipi- 
tated with anti-cathepsin D or pepsinogen antisera as appropriate and ana- 
lyzed by SDS-PAGE  and fluorography. 
Assays and Miscellaneous Methods 
/~-hexosaminidase  and a-glucosidase  II were assayed  using 1 mM of  the ap- 
propriate 4-methylumbelliferyl  substrate at pH 4.5 and 7.0, respectively, in 
the presence of 0.1% Triton X-100 (Little et al.,  1987). Fluorescence was 
measured on an Aminco fluorimeter and compared  to enzyme-free  blanks. 
Protein was assayed  with the Bio-Rad  dye reagent using  bovine serum albu- 
min as a standard. 
Results 
Biosynthesis of Cathepsin D in ICD B Lymphoblasts 
To assess  the ability of ICD lymphoblasts to target newly 
synthesized lysosomal enzymes, we first examined the traf- 
ticking of the aspartyl protease cathepsin D. B lymphoblasts 
from an ICD patient and a  normal individual were labeled 
with psS]methionine for 30 min at 37°C and chased for 4 h 
in an excess of  unlabeled methionine. At the end of  the chase, 
cells  and  media  were  collected  separately,  the  cells  were 
lysed, and equal portions of cell lysate and media samples 
were immunoprecipitated  with antisera  specific for human 
cathepsin D. Both ICD and normal lymphoblasts synthesized 
cathepsin D  as a 47-kD precursor (Fig.  1 A, lanes C). ICD 
lymphoblasts retained ~56% of cathepsin D intracellularly, 
while the remainder was secreted as procathepsin D  (Fig.  1 
A,  lanes  M).  Cell-associated  cathepsin  D  underwent  two 
proteolytic cleavages- removal of the ,~5-kD prosegment to 
generate mature cathepsin D and further cleavage to the 31- 
kD heavy chain-which  in other cells  indicate delivery to 
lysosomes (Hasilik and Neufeld,  1980a; Gieselmann et al., 
1983; Faust et al.,  1987; Rijnboutt et al.,  1992).  In normal 
lymphoblasts,  >95 % of cathepsin D  remained intracellular 
and  was almost completely processed to the 31-kD heavy 
chain. By contrast, ICD fibroblasts secreted >90% of newly 
synthesized  cathespin  D,  while  normal  human  fibroblasts 
sorted >90% of cathepsin D to lysosomes as judged by pro- 
teolytic processing  (Fig.  1 B). 
To confirm that cathepsin  D  was sorted to lysosomes in 
ICD lymphoblasts,  lymphoblasts labeled  with  psS]methio- 
nine  were  homogenized and  fractionated  on  36%  Percoll 
density gradients. Gradient fractions were then immunopre- 
cipitated with antisera to cathepsin D and assayed for a num- 
ber of  organelle marker enzymes. Virtually all of  the mature, 
proteolytically processed cathepsin D was present in a dense 
Figure 1. Sorting of cathepsin D in I-cell disease  and normal cells. 
Cultures of (A) ICD and normal lymphoblasts or (B) ICD and nor- 
real  fibroblasts  were labeled  with  pSS]methionine  for 30 min at 
37°C and chased in excess unlabeled  methionine for 0 or 4 h, as 
indicated.  Equivalent samples of a detergent  lysate of cells (C) and 
media (M) were immunoprecipitated with anti-cathepsin  D antise- 
rum.  The immunoprecipitates were analyzed by SDS-PAGE and 
fluorography. Positions of  procathepsin D (proCD), mature cathep- 
sin D (CD), and cathepsin D heavy chain (HC) are indicated to the 
left of each panel. 
("ol.08-1.12  g/ml)  compartment enriched  in the lysosomal 
marker ~-hexosaminidase (Fig.  2, A and B, fractions 3-5). 
The small amount of procathepsin D  remaining in the cells 
was present in lighter compartments (Fig. 2 A, fractions 11 
and 12) enriched in the ER marker ~t-glucosidase but also 
containing Golgi and endosomal membranes.  Quantitation 
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Figure 2. Cathepsin D is transported to dense lysosomes.  ICD lym- 
phoblasts  were labeled  as described in the legend to Fig.  1. Cells 
were homogenized, and the postnuclear supernatant  (PNS) was 
fractionated on a 36% (vol/vol) Percoll density gradient. 1-ml frac- 
tions (1  =  bottom) were collected and analyzed. (A) cathepsin D 
immunoprecipitation. Immunoprecipitates were analyzed by SDS- 
PAGE and fluorography. Positions of procathepsin D and cathepsin 
D are indicated.  In this experiment,  cells were preincubated with 
the protease inhibitors  pepstatin A and leupeptin  before labeling. 
Therefore,  cathepsin D heavy chain is not seen.  (B) Distribution 
of  cathepsin D forms in A. Appropriate regions of  the dried gel were 
excised,  and radioactivity determined by liquid scintillation  count- 
ing. Values are expressed  as a percentage of the total radioactivity 
recovered from the gradient for that species. (C) Distribution  of  the 
lysosomal marker/~-hexosaminidase,  the ER marker a-glucosidase 
II, and density profile across the gradient. Recovery of enzyme ac- 
tivity from the gradient was >80% of that loaded. 
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newly synthesized cathepsin D was retained, and that 80 % 
of this was present in dense lysosomes. Transfer of cathepsin 
D to the lysosomal compartment was first detected after 60- 
rain chase at 37°C (not shown), indicating rapid delivery to 
this organdie. Similar experiments performed with normal 
lymphoblasts showed that virtually all cell-associated cathep- 
sin D was present in dense lysosomes (not shown). 
Analysis of Cathepsin D Oligosaccharides 
Cathepsin D  has two N-linked glycosylation sites, both of 
which are used. In normal mammalian cells (Hasilik and 
Neufeld, 1980b;  Schulze-Lohoff  et al.,  1985) and Xenopus 
oocytes (Faust et al., 1987), cathepsin D is an excellent sub- 
strate for phosphotransferase and acquires Man-6-P  resi- 
dues. Despite the nearly total absence of phosphotransferase 
activity in ICD lymphoblast lysates (Little et al., 1987),  we 
wished  to  directly exclude the possibility that  lysosomal 
sorting could be due to a low but detectable level of phos- 
phorylation. The processing of cathepsin D oligosaccharides 
was first examined by treating cathepsin D immunoprecipi- 
rates with endo H, which releases high mannose-type but not 
complex-type oligosaccharides from the polypeptide back- 
bone. Cathepsin D synthesized during a 30-min pulse with 
[35S]methionine contained two Endo H-sensitive oligosac- 
charides (Fig.  3 A, Pulse). After a  four hour chase, both 
secreted and cellular cathepsin D  contained a  mixture of 
molecules, some of which were partially sensitive to endo 
H while the others were completely resistant (Fig. 3 A, Cell 
and Media). This indicates that a portion of the molecules 
contain one high mannose and one complex-type oligosac- 
charide while the rest contain two complex-type units. Since 
the 31-kD  heavy chain, which contains the carboxyl lobe 
oligosaccharide, was completely resistant to endo H diges- 
tion (Fig. 3 A, Cell) and shifted slightly on neuraminidase 
digestion (Fig. 3 B), the carboxyl lobe oligosaccharide must 
be completely processed to a sialylated complex-type spe- 
cies. The amino lobe oligosaccharide, therefore, must con- 
tain a mixture of high mannose and complex-type units. The 
molecular weight decrease observed for the cell-associated 
and  secreted  cathepsin  D  upon  neuraminidase  digestion 
(Fig. 3 B) can be accounted for by the release of sialic acid 
from the complex-type oligosaccharides.  In  normal  lym- 
phoblasts,  both  of the  cathepsin  D  oligosaccharides  re- 
mained Endo H-sensitive during  a  four hour  chase  (not 
shown). 
Since previous  studies  have  established  that only high 
mannose-type oligosaccharides are phosphorylated (Varki 
and  Kornfeld,  1980),  the predominance of complex-type 
oligosaccharides on ICD lymphoblast cathepsin D indicated 
that they contained little if any Man-6-P. To further assess 
phosphorylation, we applied [35S]methionine-labeled  lym- 
phoblast  lysates to  Man-6-P/IGF-II  receptor  affinity col- 
umns  and  immunoprecipitated the  unbound  and  Man-6- 
P-eluted column fractions with cathepsin D antiserum. As 
shown in Fig. 3 C, virtually all of the cathepsin D synthe- 
sized by normal B lymphoblasts bound to the column and 
was eluted by 10 mM Man-6-P, demonstrating efficient  phos- 
phorylation. By contrast, all cellular cathepsin D  synthe- 
sized by ICD lymphoblasts  passed through the cohmm. Iden- 
tical results were obtained with cathepsin D secreted into the 
medium (not shown). Since binding to the Man-6-P/IGF-II 
Figure 3. Analysis of cathepsin D oligosaccharides. ICD lympho- 
blasts transfected with human cathepsin D (A and B) or untrans- 
fected  normal  and  ICD  lymphoblasts (C)  were labeled with 
[35S]methionine as described in the legend to Fig. 1 unless other- 
wise noted. (A) Endo H digestion. Cell lysates and media samples 
were  immunoprecipitated with  anti-cathepsin D  antisera.  Im- 
munoprecipitates were incubated in the presence (+) or absence 
(-) of endo H and analyzed by SDS-PAGE and fluorography.  (B) 
Neuraminidase digestion. Cell lysate (C) and media samples (M) 
were incubated in the  presence (+)  or absence (-)  of Vibrio 
cholerae neuraminidase. Digested samples were immunoprecipi- 
tated with anti-cathepsin  D antisera and analyzed as inA. (C) Man- 
6-P/IGF-II receptor  affinity chromatography. Normal and ICD 
lymphoblasts were labeled for 30 min with [35S]methionine and 
chased for 2  h  at 37°C. Cell lysates were applied to receptor 
columns and unbound (RD and Man-6-P eluted (M6P) fractions 
were analyzed by immunoprecipitation as in B. 
receptor is a sensitive indicator of acquisition of Man-6-P 
residues (Baranski et al., 1990),  we conclude that cathepsin 
D  is not detectably phosphorylated in ICD lymphoblasts, 
consistent with the diagnosis of ICD. 
Glycopepsinogen  Is Not Sorted to Lysosomes 
of  ICD Lymphoblasts 
Cathepsin D and pepsinogen are both members of the aspar- 
tyl protease family, and the human enzymes share about 45 % 
amino acid sequence identity. The crystallographic struc- 
tures of seven members of this family have been solved, and 
all family members show a remarkable conservation of sec- 
ondary and tertiary structure (Davies, 1990). While cathep- 
sin  D  is  a  lysosomal enzyme,  pepsinogen  is  a  non-gly- 
cosylated  secretory  protein.  We  reasoned  that  if  the 
lysosomal targeting pathway in ICD lymphoblasts is selec- 
tive for lysosomal enzymes, then pepsinogen should not be 
targeted to lysosomes in these cells. Previous work (Baran- 
ski et al.,  1990) has demonstrated that a glycosylated form 
of pepsinogen  (glycopepsinogen)  is  a  poor  substrate  for 
phosphotransferase and  so  is  excluded  from  the  Man-6- 
P-dependent lysosomal targeting pathway. 
ICD lymphoblasts were electroporated with vectors con- 
raining a gene for hygromycin  B resistance and cDNAs cod- 
ing for human cathepsin D, human glycopepsinogen, or no 
insert, and stably transfected cell lines expressing the trans- 
fected genes were then selected for resistance to hygromycin 
B. These cell lines were used in metabolic labeling experi- 
ments similar to those described in Figs. 1 and 2. The results 
of typical experiments are shown in Fig. 4. While cathepsin 
D-transfected cells express the enzyme at approximately 10 
times  the  endogenous  level,  the  transfected protein  was 
transported to lysosomes almost as efficiently  as the endoge- 
nous cathepsin D (Fig. 4 A). Quantitation of  multiple experi- 
ments showed that 47  +  1% (n =  29 under all conditions) 
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sinogen.  Stably transfected ICD lymphoblasts were labeled with 
[3~S]methionine as described in the legend to Fig. 1. Percoll gra- 
dient analysis was performed as described in the legend to Fig. 2. 
Samples were immunoprecipitated with antisera to cathepsin D (A 
and B) or pepsinogen (C and D). (A) Sorting assays of  vector trans- 
fected and cathepsin D (cath D) transfected cells. (B) Percoll gra- 
dient analysis of cathepsin D transfected cells. (C) Sorting assays 
of vector transfected  and  glycopepsinogen (mpep12)-transfected 
cells. (D) Percoll gradient analysis of glycopepsinogen transfected 
cells. In these experiments, cells were preincubated with protease 
inhibitors before labeling as described in Materials and Methods. 
of transfected cathepsin D remained intracellular vs 56% of 
endogenous cathepsin  D.  Percoll gradient fractionation of 
p~S]methionine labeled  lymphoblast lysates  revealed that 
70%  of intracellular transfected cathepsin had been trans- 
ported  to  dense  lysosomes  versus  80%  for  endogenous 
cathepsin D  (Fig. 4  B).  Thus, overexpression of cathepsin 
D resulted in a 29% decrease in the efficiency of its sorting, 
although the absolute number of  molecules targeted to dense 
lysosomes was increased. 
In contrast to these findings with cathepsin D, the trans- 
fected glycopepsinogen was largely secreted by the ICD lym- 
phoblasts (Fig. 4  C).  Endo H  digestion demonstrated that 
both oligosaccharides on glycopepsinogen were processed to 
complex-type  chains (data not shown). Over multiple sorting 
assays, 12 -1- 1% (n =  8) of newly synthesized glycopepsino- 
gen remained intracellular. To protect intracellular protein 
from degradation, cells were routinely preincubated in me- 
dia containing the protease inhibitors leupeptin and pepsta- 
tin A before labeling (see Materials and Methods). Although 
this  treatment  had  no  effect on  the  intracellular  level of 
cathepsin D,  the corresponding value for glycopepsinogen 
rose to 20  +  1%  (n  =  16).  Under these conditions,  the 
majority of cell-associated glycopepsinogen contained pro- 
cessed oligosaccharides and was found in light-density com- 
partments  (Fig.  4  D),  probably Golgi  complex or  endo- 
somes. This relative distribution did not change with longer 
chase  times  (data  not  shown),  indicating  that  the  light- 
density pool of glycopepsinogen was not simply being trans- 
ported to lysosomes very slowly.  Overall, 5  5:1% of newly 
Figure 5.  Sorting of nonglycosylated cathepsin D. ICD lympho- 
blasts transfected with a mutant cathepsin D lacking glycosylation 
sites (CD~bl~b2) were labeled for 1 h with [35S]methionine  at 28°C 
and chased for 16 h at this temperature. Cells were preincubated 
with protease inhibitors before labeling as described in Materials 
and Methods. Samples were immunoprecipitated with antisera to 
cathepsin  D and analyzed by SDS-PAGE and fluorography. (A) 
Sorting assay. Positions of endogenous cathepsin I3, CDq~l$2, and 
a 45-kD molecular weight standard are indicated. (B) Percoll gra- 
dieut fractionation, performed as described in the legend to Fig. 2. 
Positions of 45- and 30-kD molecular weight standards are indi- 
cated. 
synthesized glycopepsinogen was transported to dense lyso- 
somes in our experiments. In addition, similar studies with 
immunoglobulin M, a major secretory protein of B lympho- 
cytes, failed to show any significant targeting of this protein 
to lysosomes, even when cells were preincubated with pro- 
tease inhibitors (results not shown). We conclude that these 
two secretory proteins are poor substrates for the ICD lym- 
phoblast lysosomal transport pathway. 
Nonglycosylated Cathepsin D Is Sorted to Lysosomes 
The ICD lymphoblasts' ability to target cathepsin D but not 
glycopepsinogen suggests that a selective recognition event 
underlies lysosomal transport of cathepsin D. This could oc- 
cur through recognition of a cathepsin D protein determinant 
absent from pepsinogen,  or,  by analogy to the Man-6-P- 
dependent pathway,  through a previously unrecognized dif- 
ference in oligosaccharide structure.  To test more directly 
whether a carbohydrate determinant was necessary for sort- 
ing, ICD lymphoblasts were transfected with a cDNA encod- 
ing a mutant cathepsin D lacking both its N-linked glycosyla- 
tion sites. This protein was sorted to dense lysosomes and 
underwent the same proteolytic processing as glycosylated 
cathepsin D (Fig. 5), although the efficiency of sorting was 
slightly lower than that of  the wild-type transfected cathepsin 
D (44 % vs. 47 % intracellular, n  =  3, with 60 % vs. 70 % of 
this amount in dense lysosomes). These results establish that 
N-linked carbohydrate residues are not essential for Man-6- 
P-independent sorting in ICD lymphoblasts. 
Identification of Cathepsin D Residues Involved in 
Lysosomal Sorting 
Having excluded N-linked carbohydrates as  sorting deter- 
minants for the Man-6-P-independent pathway, we hypothe- 
sized that amino acid sequence differences between cathep- 
sin D and pepsinogen most likely account for the selective 
lysosomal targeting of  cathepsin D. To identify the sequences 
required for sorting, we analyzed the behavior of transfected 
cathepsin D/glycopepsinogen chimeras, reasoning that the 
substitution of appropriate cathepsin D residues into the ho- 
mologous position in the pepsinogen sequence should con- 
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lysosomal sorting. The various chimeric proteins tested are shown 
schematically with  the  open bars  representing cathepsin  D  se- 
quence  and  the  solid  lines  representing  pepsinogen  sequence. 
Transfected lymphoblasts were preincubated with protease inhibi- 
tors  as  described  in  Experimental  Procedures,  labeled  with 
[35S]methionine for 1 h at 28°C and chased for 16 h at 28°C fol- 
lowed by 4 h at 37°C. Control experiments (not shown) indicated 
that the additional chase at 37°C improved  the secretion of  chimeric 
proteins  without  affecting their  stability.  Immunoprecipitation, 
SDS-PAGE and fluorography of pulse (P), cell lysate (C), and me- 
dia (M)  samples were performed as described  in Materials and 
Methods.  Appropriate  regions  of dried  gels  were  excised and 
counted, and percent sorting was calculated as cellular radioactiv- 
ity divided by total recovered radioactivity (cells plus media). Per- 
cent sorting values represent the mean + standard error of multiple 
determinations. The fraction of intracellular chimeric protein in 
dense lysosomes (enriched in/3-hexosaminidase activity; typically 
Percoll gradient fractions 2--4) was determined by Percoll gradient 
fractionation  of  [35S]methionine-labeled cell  homogenates  fol- 
lowed  by  immunoprecipitation,  SDS-PAGE, and  fluorography. 
This fraction (single value or mean of multiple determinations, as 
indicated) was multiplied by the percent sorting value to obtain per- 
cent in dense lysosomes. The recovery of immunoprecipitable pro- 
tein at the end of the chase compared to the initial pulse value was 
as follows (mean ±  S.E.): Cathepsin D (136 ±  8%), mpepl2 (92 
±  6%), CP69 (106 ±  8%), CP2 (106 ±  6%),  CP3 (93 +  6%), 
CP71 (129 +  18%), CP4 (45 5: 3%), CP6 (98 ±  10%), and CP72 
(33  ±  4%). 
vert this secreted protein into a  lysosomally targeted one. 
Similarly, the substitution of the homologous pepsinogen se- 
quence for the critical cathepsin D elements should give rise 
to a chimeric protein that is secreted rather than targeted to 
lysosomes.  This  approach  has  been  successfully used  to 
define the phosphotransferase recognition marker (Baranski 
et al.,  1990). 
In our previous study, a large number of cathepsin D/pep- 
sinogen chimeric proteins were expressed in Xenopus oo- 
cytes and, with a few exceptions, were noted to fold properly 
and exit the ER similar to the native proteins (Baranski et 
al.,  1990,  1991). However, when the biosynthesis of several 
of these same chimeric proteins was examined in transfected 
B lymphoblasts, we found that most of these proteins were 
degraded soon after synthesis at 37°C (data not shown). This 
degradation presumably took place in the ER as a result of 
improper  folding  of  the  chimeric  protein  (Hurtley  and 
Helenius,  1989).  Since these chimeric proteins had folded 
stably in Xenopus oocytes maintained at  19°C,  we tested 
whether  lowering  the  incubation  temperature  during  the 
metabolic labeling period would allow proper protein fold- 
ing and exit from the ER in B lymphoblasts. We found that 
when the metabolic labeling experiments were performed at 
28°C rather than 37°C, most of  the chimerics were no longer 
degraded and  were transported out of the  ER with good 
efficiency (see below).  Lowering the temperature to 28°C 
did not significantly alter the behavior of cathepsin  D  or 
glycopepsinogen in the sorting assays, although longer chase 
times (12-18 h) were required for complete lysosomal deliv- 
ery or secretion of the labeled proteins, consistent with ear- 
lier studies (Braulke et al.,  1988). Accordingly, the sorting 
of the various chimeric proteins was analyzed at 28°C. In ad- 
dition, the cells were preincubated with protease inhibitors 
to minimize intracellular degradation, as described above. 
Under these conditions, the recovery of eight of the chimeric 
proteins after a 20-h chase period ranged from 93 to 141% 
of the value obtained at the end of the pulse period. These 
values were the same as those determined for cathepsin D 
(136 =t= 8% recovery)and glycopepsinogen (92 +  6% recov- 
ery). In  seven other chimeric proteins partial degradation 
was observed with recoveries ranging from 72%  to 33%. 
The recovery of each construct is given in the legends to 
Figs.  6,  8, and 9. 
Carboxyl Lobe Sequences Contain 
Man-6-P-Independent Lysosomal 
Targeting Information 
We  first analyzed a  series  of chimeric proteins  in  which 
amino-terminal  cathepsin  D  residues  were  progressively 
replaced by pepsinogen residues.  The results are summa- 
rized in Fig. 6. Cathepsin D and pepsinogen are bilobed pro- 
teins, and in construct CP69 most of the cathepsin D amino 
lobe is replaced by pepsinogen residues whereas in construct 
CP2 all of the amino lobe plus some of the carboxyl lobe ele- 
ments are replaced by pepsinogen sequences.  When these 
constructs were expressed, the resultant chimeric proteins 
were retained intracellularly and sorted to lysosomes nearly 
as  well as  cathepsin  D  (23  and  20%  in  dense lysosomes 
versus 32% for cathepsin D and 5% for glycopepsinogen). 
Lysosomal targeting of these chimeric proteins was accom- 
panied by efficient cleavage of the pro-segment, indicating 
that these proteins had folded well enough to undergo acid- 
induced autoactivation (Fig.  7 A).  These results show that 
the carboxyl lobe elements of cathepsin D are sufficient to 
direct efficient lysosomal sorting. 
The next constructs were designed to localize the critical 
elements  in  the  carboxyl lobe.  In  CP3,  an  additional 42 
amino acids in the carboxyl lobe of cathepsin D  were re- 
placed by analogous pepsinogen residues. Expression of this 
construct  resulted in  a  chimeric protein that  was  poorly 
sorted relative to CP2 (9% in dense lysosomes versus 20%). 
This result indicates that cathepsin D amino acids 188 to 230 
(cathepsin D numbering [Faust et al., 1985] is used through- 
out) are necessary for efficient sorting. The poor sorting of 
CP71, which contains only the 26 COOH-terminal residues 
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teins. Transfected ICD lymphoblasts were labeled with [35S]methi- 
onine as described in the legend to Fig. 6, cells were homogenized, 
and postnuclear supernatants  were fractionated on 36%  Percoll 
gradients. Equal portions of each fraction (1 = bottom) were ana- 
lyzed by immunoprecipitation, SDS-PAGE, and fluorography. 
of cathepsin D, is consistent with this conclusion. Both CP3 
and  CP71  were highly  secreted,  indicating  that  they had 
folded adequately to exit the ER. 
Constructs CP4, CP6, and CP72 were prepared to deter- 
mine which portions of the cathepsin D carboxyl lobe were 
sufficient to  direct the  chimeric protein to the lysosome. 
CP4, which contains cathepsin D residues 188 to 230 in the 
pepsinogen background, was sorted relatively poorly (6 % in 
dense lysosomes). The inclusion of cathepsin D residues 320 
to 346 with residues  188 to 230 (construct CP72) did not 
augment the lysosomal sorting  (5 %  in dense lysosomes). 
However, since the recovery of both of these chimeric pro- 
teins was relatively low (45  5:3 % for CP4 and 33  +  4 % 
for CP72), the targeting of these proteins to lysosomes may 
have been underestimated.  CP6,  which  contains  residues 
188 to 265 of cathepsin D  sequence, was targeted to lyso- 
somes as well as CP2, which contains most of the cathepsin 
D  carboxyl lobe  (19%  in  dense  lysosomes  versus  20%, 
respectively;  Figs.  6  and  7  B).  These  results  show  that 
cathepsin D residues 188 to 265 can act to direct lysosomal 
sorting of glycopepsinogen. 
Cathepsin D Residues 188 to 230 Are Required for 
E~cient Lysosomal Sorting 
While the preceding experiments show that the carboxyl lobe 
segment 188 to 265 of cathepsin D  is sufficient to form a 
lysosomal sorting signal, the significant difference in sorting 
efficiency  between CP6 and cathepsin D (19 vs 32 %) clearly 
indicates that other cathepsin D regions contribute to sort- 
ing. In addition, these cathepsin D regions could potentially 
direct lysosomal sorting in the absence of the carboxyl lobe 
region. To assess this possibility, we assayed the sorting of 
chimeric proteins in which various carboxyl lobe elements 
of cathepsin D  were replaced by analogous pepsinogen se- 
quences. Constructs CP55 and CP56, in which cathepsin D 
residues  188  to  230  and  188  to  265,  respectively,  were 
Figure 8. Cathepsin D carboxyl lobe residues 188 to 230 are neces- 
sary for efficient lysosomal sorting. Experimental details are de- 
scribed in the legend to Fig. 6. CP52, CP55, and CP56 were immu- 
noprecipitated  with  antisera  to  cathepsin  D;  therefore,  some 
(=10%) of the radioactive signal detected corresponds to the en- 
dogenously expressed cathepsin D. The recovery of immunopre- 
cipitable protein at the end of  the chase compared to the initial pulse 
value was as follows  (mean + SE): Cathepsin D (136 ± g%), CP55 
(123 ±  11%), CP56 (131 ±  7%), CP52 (72  ±  6%), CP51 (141 
±  14%), and CP65 (67 ±  2%). 
replaced, were significantly impaired in sorting (11 and 10% 
in dense lysosomes, respectively; Fig. 8). Both of these chi- 
meric proteins were highly secreted, and the majority of the 
retained material was present as the proenzyme in light den- 
sity compartments (Fig. 7  C). The chimeric protein in this 
compartment contained complex-type oligosaccharides, in- 
dicative of passage through the Golgi cisternae, although its 
exact intracellular location is unclear. This pool appeared to 
be stable since the extent of secretion and the distribution of 
the chimeric proteins on Percoll gradients did not Change 
even after extended chase times (not shown). These results 
are consistent with cathepsin D residues 188 to 265 contain- 
ing the most potent lysosomal sorting determinants. Further 
evidence to support this conclusion comes from a compari- 
son of the results obtained with constructs CP69 (Fig. 6) and 
CP65 (Fig. 8). CP69, which contains cathepsin D residues 
130 to 348, is efficiently sorted to dense lysosomes (23%) 
whereas  CP65,  which  differs  from CP69  by  lacking  the 
cathepsin D  residues  188 to 265, is mostly secreted. 
Constructs CP52 and CP51 differ from CP55 in also hav- 
ing cathepsin D residues 265 to 292 and 265 to 319, respec- 
tively, substituted with pepsinogen sequence (Fig. 8). Both 
of these chimeric proteins were impaired in sorting although 
they were targeted to dense lysosomes slightly more effi- 
ciently than CP55 (14% for each versus 11% for CP55). One 
possibility is that these chimeric proteins fold in such a way 
as to express a lysosomal sorting signal located within cathep- 
sin D  residues 230 to 265 that remains cryptic in CP55. 
Involvement of  Phosphotransferase 
Recognition Marker Elements in 
Man-6-P-independent Lysosomal Sorting 
In previous studies, we demonstrated that two noncontiguous 
primary sequences from the carboxyl lobe of cathepsin D 
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perimental details are described in the legend to Fig. 6. The recov- 
ery of  immunoprecipitable protein at the end of  the chase compared 
to the initial pulse value was 48 +  3%, 55 +  6%, and 43 +  13% 
of CP5, CPIT, and CP73, respectively. 
(amino acids 188 to 230, particularly lysine 203, and 265 to 
292) were sufficient to generate an efficient  phosphotransfer- 
ase recognition domain in glycopepsinogen. (Baranski et al., 
1990). The involvement of the first region as a component 
of the Man-6-P-independent lysosomal sorting signal sug- 
gested the possibility that there may be a  relationship be- 
tween the two signalling motifs.  Since lysine 203 is a key 
component of the phosphotransferase recognition motif, we 
tested whether this residue is important for the Man-6-P- 
independent lysosomal sorting pathway. When lysine 203 was 
changed to an alanine in the context of cathepsin D residues 
188 to 265 (construct CP73), the resultant chimeric protein 
was sorted as well as CP6, the equivalent chimeric protein 
containing lysine 203  (21%  of CP73  in dense lysosomes, 
Fig.  9,  versus  19%  of CP6,  Fig.  6).  CP5 and CP17 were 
tested  to  determine  whether  lysine  203  might  enhance 
lysosomal sorting when expressed alone in the pepsinogen 
background. CP5 contains only cathepsin D residues 265 to 
348 whereas CP17 is identical except for a glutamic acid-to- 
lysine mutation at position 203 (Fig. 9).  When expressed, 
CP5 was sorted at the baseline level (9 % in dense lysosomes) 
while CP17 was sorted at an intermediate level (16 % in dens~ 
lysosomes). These results indicate that lysine 203 contrib- 
utes to the Man-6-P-independent lysosomal sorting, but that 
other residues in the 188 to 265 region of cathepsin D can 
compensate for its  absence.  The analysis  of further con- 
structs  involving residue  203  will be  necessary to  better 
define the relationship between this residue and other ele- 
ments of the sorting signal. 
The Chimeric Proteins Are Catalytically Active 
A useful parameter to evaluate the proper folding of an en- 
zyme is whether it is catalytically active. This is particularly 
helpful in the case of the aspartyl proteases since the active 
site contains one aspartic acid residue (Asp 33 and Asp 231) 
contributed by each lobe of  the enzyme. To examine whether 
the expressed chimeric proteins had folded correctly at 28°C, 
we took advantage of the fact that the aspartyl proteases are 
specifically inhibited by pepstatin A. This compound rever- 
Figure 10. Binding of cathepsin D and CP6 to Pepstatin A-agarose. 
Aliquots of media from transfected B lymphoblasts labeled with 
[35S]methionine were incubated with Pepstatin A agarose as de- 
scribed in Materials and Methods, in either the presence (+) or ab- 
sence (-) of free pepstatin A. Unbound (FT) and pH 8.0-eluted 
(E) fractions were analyzed by immunoprecipitation, SDS-PAGE, 
and fluorography. (A) Cathepsin D-transfected ceils. Samples were 
immunoprecipitated with antisera to cathepsin D. (B) CP6-trans- 
fected cells.  Samples were immunoprecipitated with antisera to 
pepsinogen. 
sibly binds to the active site in a strictly pH-dependent man- 
ner (Davies,  1990). As shown in Fig.  10 A, the expressed 
cathepsin D bound to pepstatin A-agarose at pH 3.6 and was 
eluted at pH 8.0. This binding was completely inhibited by 
the inclusion of free pepstatin A and did not occur at pH 7.4. 
Identical results were obtained with CP6 (Fig.  10 B) and 
with all the other chimeric proteins used in this study. 
Interestingly, all of  the proteins tested, including cathepsin 
D, exhibited acid-induced proteolysis, presumably due to au- 
tocatalytic cleavage of the prosegment, even in the presence 
of pepstatin A. The reason for this pepstatin A-resistant au- 
toactivation is unclear, but it may reflect the specific pH con- 
ditions of the experiments. At pH 3.6, as opposed to more 
strongly acidic conditions, the prosegment may not be ade- 
quately displaced from the active site of admit the inhibitor 
before autoactivation  occurs  (Marciniszyn  et  al.,  1976). 
Nevertheless, the ability of  these proteins to autoactivate and 
to bind to pepstatin A argues strongly for the proper folding 
of their active sites. 
Discussion 
The Man-6-P-independent lysosomal targeting pathway in 
mammalian cells has been known to exist for over a decade, 
but the nature of the molecular signals that mediate this tar- 
geting have not been previously identified. The availability 
of a B lymphoblastoid cell line from a patient with ICD has 
allowed us to study the targeting of newly synthesized cathep- 
sin D to lysosomes in the absence of a Man-6-P-sorting sig- 
nal. We find that this acid protease traverses the secretory 
The Journal of Cell Biology, Volume  123, 1993  106 pathway as far as the trans-most cisternae of the Golgi com- 
plex and that about 45 % of the molecules are sorted to dense 
lysosomes while the rest of the enzyme is secreted. Since the 
cathepsin D synthesized by the ICD lymphoblasts contains 
no detectable Man-6-P,  the lysosomal targeting must be oc- 
curring by a Man-6-P-independent mechanism. This Man- 
6-P-independent pathway is less efficient than the Man-6- 
P-dependent one expressed in normal lymphoblasts. ICD 
fibroblasts appear to lack the Man-6-P-independent pathway 
since they secrete almost all their newly synthesized cathep- 
sin D (Hasilik and Neufeld, 1980a,b;  and this study). Di- 
Cioccio and Miller (1991) have reported that the lysosomal 
hydrolase Oe-L-fucosidase is retained intracellularly in ICD 
lymphoblasts even though it is not phosphorylated. Although 
cell fractionation was not performed in that study to verify 
lysosomal targeting, comparison with the results presented 
here suggests that cathepsin D is sorted more efficiently than 
oe-L-fucosidase. 
The sorting of proteins to lysosomes via the Man-6-P- 
independent pathway is selective for acid hydrolases. In our 
experiments, 32 % of transfected cathepsin D was targeted to 
dense lysosomes versus 5 % of the homologous secretory 
protein, glycopepsinogen. Similar pulse-chase experiments 
following the fate of immunoglobulin M, a major secretory 
protein of B lymphocytes, failed to show any significant tar- 
geting of this protein to lysosomes, even when cells were 
preincubated with protease inhibitors to prevent lysosomal 
degradation. These results indicate that the lysosomal target- 
ing of cathepsin D is not the result of nonspecific "spillover" 
from the constitutive secretory pathway. 
The major goal of this study was to identify the structural 
determinants required for protein targeting to lysosomes via 
the Man-6-P-independent pathway.  The finding that non- 
glycosylated cathepsin D was targeted to lysosomes almost 
as efficiently  as normal cathepsin D indicated that the cathep- 
sin D amino acid sequence must contain the specific sorting 
signal(s). By making chimeric proteins between cathepsin D 
and glycopepsinogen, which lacks the sorting signal even 
though it shares 45%  amino acid sequence identity with 
cathepsin D, we have been able to identify elements of the 
signal. The analysis of a number of cathepsin D/glycopep- 
sinogen chimeric proteins reveals that amino acids  188 to 
265 of the cathepsin D carboxyl lobe are capable of directing 
efficient sorting to lysosomes. Within this region amino acids 
188 to 230 are essential for this sorting, but appear to require 
residues 230 to 265 to form an active signal. In addition, 
since CP6, which contains cathepsin D residues 188 to 265, 
is not sorted as well as cathepsin D, it is likely that other 
regions of the cathepsin D molecule contribute to the sorting 
signal. Examination of the location of amino acids  188 to 
265 in the crystal structure of porcine pepsinogen (Baranski 
et al., 1990) reveals that they form an extended surface do- 
main on the carboxyl lobe. One residue within this domain, 
lysine 203,  appears to contribute to the sorting signal al- 
though other residues in this region can compensate for its 
absence. 
The finding that amino acids 188 to 265 function as a sort- 
ing signal for the Man-6-P-independent targeting pathway is 
of particular interest in view of our current understanding of 
the phosphotransferase recognition domain on cathepsin D. 
We have found that the combined substitution of two regions 
of cathepsin D (amino acids 188 to 230, particularly lysine 
203, and amino acids 265 to 292) into the analogous posi- 
tions of glycopepsinogen generates a strong recognition do- 
main for phosphotransferase. These two sequences are in di- 
rect apposition on the surface of the molecule and appear to 
form a surface patch that contains multiple interacting sites 
(Baranski et al.,  1990, 1991). It is apparent that the deter- 
minants required to form the signal for the Man-6-P-inde- 
pendent targeting pathway overlap with the first region of the 
phosphotransferase recognition motif. Furthermore, lysine 
203 seems to form part of both signals. These results, taken 
together, lead us to conclude that the two determinants over- 
lap but are not identical. 
While the actual function of the cathepsin D carboxyl lobe 
elements in the Man-6-P-independent sorting pathway re- 
mains to be elucidated, the simplest explanation is that these 
determinants allow binding to a receptor in the Golgi com- 
plex which then delivers the bound ligand to the lysosome 
or to a prelysosomal compartment. The fact that the efficiency 
of endogenous cathepsin D  sorting is 45 % and the finding 
that the sorting is decreased to 32 % when cathepsin D is ten- 
fold overexpressed suggests that the putative receptor system 
may be of limited capacity. This model would also explain 
the observation that the Man-6-P-independent sorting path- 
way only functions in selected cell types if  the receptor is ex- 
pressed in a cell type-specific manner. However, other mech- 
anisms could account for the Man-6-P-independent sorting, 
such as a model in which the various acid hydrolases would 
selectively aggregate with each other and interact with a 
membrane component in the Golgi complex. This type of 
mechanism is currently believed to mediate the sorting of 
proteins to secretory granules (Miller and Moore,  1990). 
We are currently trying to identify cellular component(s) 
that recognize non-phosphorylated cathepsin D in order to 
determine which of these models is operative. 
In studying the delivery of transfected chimeric proteins 
to the lysosome, it is necessary to distinguish an active sort- 
ing process from nonspecific targeting of  misfolded proteins. 
There are several reasons why we believe we are observing 
the former process rather than the latter. First, all the con- 
structs used in this study acquired endo H-resistant oligo- 
saccharides and were secreted to variable extents, indicating 
that they had folded sufficiently to exit the ER.  Chimeric 
constructs which did not meet these criteria were considered 
noninformative. Second, the sorting values for the various 
chimeric proteins  fell between those of cathepsin D  and 
glycopepsinogen, consistent with the notion that the inter- 
change of cathepsin D and pepsinogen residues destroys or 
generates a sorting signal present in cathepsin D but absent 
in  pepsinogen.  Finally,  all  the  chimeric  proteins  bound 
specifically and quantitatively to pepstatin A-agarose. There- 
fore, the aspartyl protease active site of  each of  these proteins 
must have folded sufficiently well to bind a small molecule 
competitive inhibitor. Since each lobe contributes an active 
site aspartic acid to the binding cleft, the overall bilobed 
structure must also be intact. Nevertheless, five of the fifteen 
chimeric proteins (CP4, CP5, CP17, CP72, and CP73) did 
exhibit a significant turnover during the chase period, with 
between 45 % and 67 % of the molecules being degraded. Al- 
though most of this degradation probably occurred in the 
ER, it is possible that the actual delivery of these chimeric 
proteins to lysosomes was underestimated. Even if this were 
the  case,  the  conclusions  regarding  the  importance  of 
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would not be significantly altered since all the critical con- 
structs  (CP2, CP3, CP6, CP55, and CP56) survived as well 
as cathepsin D  and glycopepsinogen. 
Several investigators (Diment et al.,  1988;  Mclntyre and 
Erickson,  1991;  Rijnboutt  et al.,  1991)  have found that the 
precursor forms of cathepsin  D  and other lysosomal pro- 
teases become membrane associated during their biosynthe- 
sis in a variety of cell types, and that this association appears 
to occur independently of Man-6-P residues. These findings 
provide some evidence for an unrecognized lysosomal en- 
zyme binding protein which could play a role in targeting. 
However, since membrane association in these studies was 
observed  primarily  in  endosomes  and  only  at  relatively 
acidic pH, the relationship of this phenomenon to lysosomal 
enzyme sorting in the Golgi is uncertain at present. Studies 
in  the  yeast  Saccharomyces cerevisiae have  demonstrated 
that amino acids in the propeptides of proteinase A and car- 
boxypeptidase Y are sufficient to direct the sorting of these 
soluble proteins to the lysosome-like vacuole (Johnson et al., 
1987;  Klionsky et al.,  1988;  Vails et al.,  1990).  This con- 
trasts  with our findings  which fail to  show a role for the 
cathepsin D propiece in lysosomai targeting.  However, in the 
case of proteinase A, an aspartyl protease which shows 46 % 
identity in amino acid sequence with cathepsin D, the possi- 
bility of a second sorting signal in the mature protein could 
not be excluded (Klionsky et al.,  1988).  The possible rela- 
tionship between the yeast vacuolar sorting pathway and the 
system  we  have  characterized  in  human  B  lymphoblasts 
should become clearer as the components of the two systems 
are further  characterized. 
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